Melanotan I
Also known as: Afamelanotide · Scenesse · NDP-MSH
An FDA/EMA-approved synthetic alpha-MSH analog that stimulates protective skin pigmentation. Used clinically for Erythropoietic Protoporphyria (EPP).
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
~30 minutes
1 mg (implant) every 2 months
Subcutaneous implant
Mechanism of Action
Selectively activates MC1R to stimulate eumelanin production, providing deep photoprotective pigmentation without requiring UV exposure.
Key Research Areas
Frequently Asked Questions
What is Melanotan I?▾
How does Melanotan I work?▾
What is the recommended dosage for Melanotan I?▾
What is the half-life of Melanotan I?▾
Is Melanotan I FDA approved?▾
Research Disclaimer
The information provided about Melanotan I is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.